businesswire.comBone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceedsabout 1 year ago
businesswire.comFirst Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusionabout 1 year ago
benzinga.comBone Biologics Executives to be Interviewed in a "CEO Chat" by Zacks Small-Cap Research Analyst on June 20thabout 1 year ago
businesswire.comBone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesalmost 2 years ago
CashuBone Biologics Advances Innovative Solutions in Bone Regeneration Technology for Orthopedic Care3 days ago
CashuBone Biologics (BBLG) Advances Innovative Bone Regeneration Technologies for Enhanced Patient Careabout 2 months ago
CashuBone Biologics (BBLG): Pioneering Innovations in Regenerative Medicine for Bone Healingabout 2 months ago